@debe @DavidJuurlink @AlexWodak https://t.co/idqHwQrU2M there's much, much more data on these meds for heroin & little reason to believe would be less effective, given that heroin population tends to higher severity, not lower.
Low to moderate quality evidence supporting maintenance agonist pharmacotherapy for opioid dependence. RCT limited by open label design, patient inclusion criteria and other limitations. https://t.co/wHaa5Kn8J3
@ADAWnews @MoNscience @StefanKertesz @jonathan_giftos @AlexWodak @DrSarahWakeman @lizflock @jeff_deeney @ZachWritesStuff @fletcha3 @adfoxMD @NIDAnews actually there's a cochrane review on this: https://t.co/idqHwQrU2M says they do
Read more: opioid maintenance for prescription opioids dependence- Nielsen et al's 2016 Cochrane review here https://t.co/pUxCWrcXTR #imia17
Opioid agonist treatment for pharmaceutical opioid dependent people - https://t.co/KQVxX4O5sS
Opioid maintenance medicines for the treatment of dependence on opioid pain medicines https://t.co/H1PRgD98US
Newly released Cochrane review of opioid maintenance Rx https://t.co/ViODy1KtEf
Want to blog about new Cochrane Review "Opioid agonist treatment for pharmaceutical opioid dependent people"? https://t.co/uZiaseL8MR